Clostridioides difficile is the most common cause of nosocomial antibiotic-associated
diarrhea, and is responsible for a spectrum of diseases characterized by high levels of …

Clostridioides difficile infection (CDI) is one of the major issues in nosocomial infections.
This bacterium is constantly evolving and poses complex challenges for clinicians, often …

Background Antimicrobial susceptibility testing (AST) is not routinely performed for
Clostridioides difficile and data evaluating minimum inhibitory concentrations (MICs) are …

ABSTRACT Introduction Updating data on Clostridioides difficile antibiotic resistance is
important for treatment improvement of C. difficile infections (CDIs). Areas covered Results …

The burden of emerging antimicrobial resistance (AMR) in the United States is significant
and even greater worldwide. Mitigation efforts have decreased the incidence and deaths …

Objectives To determine the frequencies and clonal distributions of putative genetic
determinants of resistance to antimicrobials applied for treatment of Clostridioides difficile …

Background Our previous study reported a high rate of recurrence in children with
Clostridioides difficile (C. difficile) infection (CDI) after conventional antibiotic therapy. Here …

TO THE EDITOR—We thank Chang et al [1] for their interest in our work [2] and the
recommendations. Regarding the issues they raised, we would like to take this opportunity …

Objectives Clostridioides difficile is an etiological agent of enteric diseases in humans and
animals. Animals are considered a potential reservoir due to the genetic and antimicrobial …

Clostridioides difficile infection (CDI) is the fifth leading cause of death from nonmalignant
gastrointestinal disease in the United States. The contribution of resistance to C. difficile …